A poorly differentiated thyroid cancer cell line PDTC-1 and applications thereof
A thyroid cancer and cell technology, applied in the direction of tumor/cancer cells, animal cells, vertebrate cells, etc., can solve the lack of credible evidence-based medical evidence, the difficulty of large-sample randomized controlled studies, and the low incidence of anaplastic thyroid cancer And other issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Example 1. Poorly differentiated thyroid cancer cell line and its preparation and application
[0020] 1. Preparation and verification
[0021] The present invention establishes the poorly differentiated thyroid cancer cell line PDTC-1 by the following method:
[0022] Cell separation and screening: The tumor specimen is an isolated specimen of poorly differentiated thyroid cancer. Fresh surgical specimens are taken, and the "fish-like" tumor tissue in the non-necrotic area is selected for cell separation and screening to obtain the target cell line, which is designated as PDTC-1 .
[0023] The cell line PDTC-1 was inoculated in PRIM 1640 medium containing 10% fetal bovine serum, and cultured in a 5% CO2 incubator at 37°C for 2 weeks to obtain the first-generation cultured cells; the first-generation cultured cells Cells were re-plated in PRIM 1640 medium with 10% fetal bovine serum at 37 °C in 5% CO 2 Cultured under incubator conditions for 2 weeks to obtain the sec...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com